Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications.

Authors:
Yan D; Song Y; Zhang B; Cao G; Zhou H and 6 more

Journal:
Stem Cell Res Ther

Publication Year: 2024

DOI:
10.1186/s13287-023-03620-0

PMCID:
PMC10763319

PMID:
38167106

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Stem Cell Res Ther

Abbreviation: Stem Cell Res Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cell Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adipose-derived stem cells in immune-related skin disease: a review of current research and underly…
Sun T; Zhou C; Lu F and 3 more (2024) - Transparency Score: 3/6
Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutatio…
Hovhannisyan Y; Li Z; Callon D and 19 more (2024) - Transparency Score: 4/6
Culture and expansion of murine proximal airway basal stem cells.
Wu M; Zhang X; Tu Y and 2 more (2024) - Transparency Score: 3/6
Culture of Hoffa fat pad mesenchymal stem/stromal cells on microcarrier suspension in vertical whee…
Otahal A; Kramer K; Neubauer M and 4 more (2024) - Transparency Score: 3/6
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration.
Ghoneim MA; Gabr MM; El-Halawani SM and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (Grants Nos. 82170336, 82270286 and 82000227), National Key R&D Program of China (2022YFC2402804), Science and Technology Research and Development Program of Shaanxi Province(2023-ZDLSF-39) and the National High Level Talents Special Support Plan."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025